|
|
Royal DSM Forms JVs with North China Pharmaceutical Group
publication date: Mar 19, 2009
Royal DSM N.V., the Dutch company involved in life sciences and materials sciences, will make a $110 million investment into North China Pharmaceutical Group Corporation Ltd. of Shijiazhuang, Hebei Province. The investment will establish three joint ventures, two in the area of anti-infectives, and a third to build a vitamin C production facility. After the investment, Royal DSM will own 10% of NCPC Group Co. DSM will hold a 51% interestin the anti-infective JVs, but its interest in the vitamin C production JV will be 30%. More details... Stock Symbols: (AMS: DSM) (SHA: 600812)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|